Search

Your search keyword '"Etienne C. Hirsch"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Etienne C. Hirsch" Remove constraint Author: "Etienne C. Hirsch" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
25 results on '"Etienne C. Hirsch"'

Search Results

2. Seven Solutions for Neuroprotection in Parkinson's Disease

3. NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients

4. Long-term outcome in neuroZika

5. Glutaredoxin 1 downregulation in the substantia nigra leads to dopaminergic degeneration in mice

6. Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease

7. Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease

8. Parkinson's disease: A target for therapies?

9. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization

10. NEUROPROTECTION OF DOPAMINE NEURONS BY XENON AGAINST LOW-LEVEL EXCITOTOXIC INSULTS IS NOT REPRODUCED BY OTHER NOBLE GASES

11. Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Techniques, Side Effects, and Postoperative Imaging

12. Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity

13. The Oxygen Paradox, the French Paradox, and age-related diseases

14. Dysfunction of mitochondrial Lon protease and identification of oxidized protein in mouse brain following exposure to MPTP: Implications for Parkinson disease

15. Hepcidin attenuates amyloid beta-induced inflamatory and pro-oxidant responses in astrocytes and microglia

16. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes

17. Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Anatomy and Terminology

18. Understanding Dopaminergic Cell Death Pathways in Parkinson Disease

19. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease

20. Dyskinesia in Parkinson’s disease: a clinical complication and an open scientific question

21. Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease

22. The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in cooperation with nicotine

23. Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease

24. The global fight against dementia

25. Comment protéger les neurones en pratique dans la maladie de Parkinson ? Voie unique ou mécanisme spécifique ?

Catalog

Books, media, physical & digital resources